The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of lisaftoclax, a novel BCL-2 inhibitor, in combination with azacitidine in patients with treatment-naïve or relapsed or refractory acute myeloid leukemia.
 
Huafeng Wang
No Relationships to Disclose
 
Xudong Wei
No Relationships to Disclose
 
Yang Liang
No Relationships to Disclose
 
Qian Jiang
No Relationships to Disclose
 
Wenjuan He
No Relationships to Disclose
 
Qiubai Li
No Relationships to Disclose
 
Jianyu Weng
No Relationships to Disclose
 
Suning Chen
No Relationships to Disclose
 
Chunkang Chang
No Relationships to Disclose
 
Hongbing Ma
No Relationships to Disclose
 
Yajing Xu
No Relationships to Disclose
 
Qun He
No Relationships to Disclose
 
Zi Chen
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Lihui Liu
Employment - Ascentage Pharma
 
Lichuang Men
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Danhua Cong
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Zhang Zhang
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Dajun Yang
Employment - Ascentage Pharma; Ascentage Pharma
Leadership - Ascentage Pharma; Ascentage Pharma; Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Yifan Zhai
Employment - Ascentage Pharma; Ascentage Pharma (I)
Leadership - Ascentage Pharma; Ascentage Pharma (I)
Stock and Other Ownership Interests - Ascentage Pharma; Ascentage Pharma (I)
 
Jie Jin
No Relationships to Disclose